Table of Content

1 T Cell-specific Surface Glycoprotein CD28 Antibody Market Overview
1.1 Product Overview and Scope of T Cell-specific Surface Glycoprotein CD28 Antibody
1.2 T Cell-specific Surface Glycoprotein CD28 Antibody Segment by Type
1.2.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Type (2024-2034)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 T Cell-specific Surface Glycoprotein CD28 Antibody Segment by Application
1.3.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value by Application: (2024-2034)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size Estimates and Forecasts
1.4.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue 2018-2029
1.4.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales 2018-2029
1.4.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 T Cell-specific Surface Glycoprotein CD28 Antibody Market Competition by Manufacturers
2.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Manufacturers (2018-2024)
2.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Manufacturers (2018-2024)
2.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Average Price by Manufacturers (2018-2024)
2.4 Global T Cell-specific Surface Glycoprotein CD28 Antibody Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Product Type & Application
2.7 T Cell-specific Surface Glycoprotein CD28 Antibody Market Competitive Situation and Trends
2.7.1 T Cell-specific Surface Glycoprotein CD28 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest T Cell-specific Surface Glycoprotein CD28 Antibody Players Market Share by Revenue
2.7.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 T Cell-specific Surface Glycoprotein CD28 Antibody Retrospective Market Scenario by Region
3.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region: 2018-2029
3.2.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region: 2018-2024
3.2.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region: 2024-2029
3.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region: 2018-2029
3.3.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region: 2018-2024
3.3.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region: 2024-2029
3.4 North America T Cell-specific Surface Glycoprotein CD28 Antibody Market Facts & Figures by Country
3.4.1 North America T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2029)
3.4.3 North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe T Cell-specific Surface Glycoprotein CD28 Antibody Market Facts & Figures by Country
3.5.1 Europe T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2029)
3.5.3 Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Market Facts & Figures by Country
3.7.1 Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2029)
3.7.3 Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa T Cell-specific Surface Glycoprotein CD28 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Type (2018-2029)
4.1.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Type (2018-2024)
4.1.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Type (2024-2029)
4.1.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Type (2018-2029)
4.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Type (2018-2029)
4.2.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Type (2018-2024)
4.2.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Type (2024-2029)
4.2.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Application (2018-2029)
5.1.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Application (2018-2024)
5.1.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Application (2024-2029)
5.1.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Application (2018-2029)
5.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Application (2018-2029)
5.2.1 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Application (2018-2024)
5.2.2 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Application (2024-2029)
5.2.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global T Cell-specific Surface Glycoprotein CD28 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Thermo Fisher
6.3.1 Thermo Fisher Corporation Information
6.3.2 Thermo Fisher Description and Business Overview
6.3.3 Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.3.5 Thermo Fisher Recent Developments/Updates
6.4 Bio-Techne
6.4.1 Bio-Techne Corporation Information
6.4.2 Bio-Techne Description and Business Overview
6.4.3 Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.4.5 Bio-Techne Recent Developments/Updates
6.5 BioLegend
6.5.1 BioLegend Corporation Information
6.5.2 BioLegend Description and Business Overview
6.5.3 BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.5.4 BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.5.5 BioLegend Recent Developments/Updates
6.6 LifeSpan BioSciences, Inc
6.6.1 LifeSpan BioSciences, Inc Corporation Information
6.6.2 LifeSpan BioSciences, Inc Description and Business Overview
6.6.3 LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.6.4 LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.7 Elabscience Biotechnology Inc.
6.6.1 Elabscience Biotechnology Inc. Corporation Information
6.6.2 Elabscience Biotechnology Inc. Description and Business Overview
6.6.3 Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.8 Boster Biological Technology
6.8.1 Boster Biological Technology Corporation Information
6.8.2 Boster Biological Technology Description and Business Overview
6.8.3 Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.8.5 Boster Biological Technology Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Merck T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Wuhan Fine Biotech Co., Ltd.
6.10.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.10.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.10.3 Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.11 ProSci Incorporated
6.11.1 ProSci Incorporated Corporation Information
6.11.2 ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Description and Business Overview
6.11.3 ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.11.4 ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.11.5 ProSci Incorporated Recent Developments/Updates
6.12 Abbexa
6.12.1 Abbexa Corporation Information
6.12.2 Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Description and Business Overview
6.12.3 Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Product Portfolio
6.12.5 Abbexa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 T Cell-specific Surface Glycoprotein CD28 Antibody Industry Chain Analysis
7.2 T Cell-specific Surface Glycoprotein CD28 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 T Cell-specific Surface Glycoprotein CD28 Antibody Production Mode & Process
7.4 T Cell-specific Surface Glycoprotein CD28 Antibody Sales and Marketing
7.4.1 T Cell-specific Surface Glycoprotein CD28 Antibody Sales Channels
7.4.2 T Cell-specific Surface Glycoprotein CD28 Antibody Distributors
7.5 T Cell-specific Surface Glycoprotein CD28 Antibody Customers
8 T Cell-specific Surface Glycoprotein CD28 Antibody Market Dynamics
8.1 T Cell-specific Surface Glycoprotein CD28 Antibody Industry Trends
8.2 T Cell-specific Surface Glycoprotein CD28 Antibody Market Drivers
8.3 T Cell-specific Surface Glycoprotein CD28 Antibody Market Challenges
8.4 T Cell-specific Surface Glycoprotein CD28 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Manufacturers (2018-2024)
Table 6. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market T Cell-specific Surface Glycoprotein CD28 Antibody Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of T Cell-specific Surface Glycoprotein CD28 Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global T Cell-specific Surface Glycoprotein CD28 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell-specific Surface Glycoprotein CD28 Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2018-2024) & (K Units)
Table 18. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2018-2024)
Table 19. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2024-2029) & (K Units)
Table 20. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2024-2029)
Table 21. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2018-2024)
Table 23. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2024-2029)
Table 25. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2024) & (K Units)
Table 27. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2024-2029) & (K Units)
Table 28. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2024) & (K Units)
Table 32. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2024-2029) & (K Units)
Table 33. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2024) & (K Units)
Table 42. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2024-2029) & (K Units)
Table 43. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Type (2018-2024)
Table 51. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Type (2024-2029)
Table 52. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Type (2018-2024)
Table 53. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Type (2024-2029)
Table 54. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Type (2018-2024)
Table 55. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Type (2024-2029)
Table 56. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Type (2018-2024)
Table 57. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Type (2024-2029)
Table 58. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2018-2024)
Table 59. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2024-2029)
Table 60. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Application (2018-2024)
Table 61. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Application (2024-2029)
Table 62. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Application (2018-2024)
Table 63. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Application (2024-2029)
Table 64. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Application (2018-2024)
Table 65. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Application (2024-2029)
Table 66. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Application (2018-2024)
Table 67. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Application (2024-2029)
Table 68. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2018-2024)
Table 69. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2024-2029)
Table 70. Sino Biological, Inc. Corporation Information
Table 71. Sino Biological, Inc. Description and Business Overview
Table 72. Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 74. Sino Biological, Inc. Recent Developments/Updates
Table 75. Abcam Corporation Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 79. Abcam Recent Developments/Updates
Table 80. Thermo Fisher Corporation Information
Table 81. Thermo Fisher Description and Business Overview
Table 82. Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 84. Thermo Fisher Recent Developments/Updates
Table 85. Bio-Techne Corporation Information
Table 86. Bio-Techne Description and Business Overview
Table 87. Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 89. Bio-Techne Recent Developments/Updates
Table 90. BioLegend Corporation Information
Table 91. BioLegend Description and Business Overview
Table 92. BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 94. BioLegend Recent Developments/Updates
Table 95. LifeSpan BioSciences, Inc Corporation Information
Table 96. LifeSpan BioSciences, Inc Description and Business Overview
Table 97. LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 99. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 100. Elabscience Biotechnology Inc. Corporation Information
Table 101. Elabscience Biotechnology Inc. Description and Business Overview
Table 102. Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 104. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 105. Boster Biological Technology Corporation Information
Table 106. Boster Biological Technology Description and Business Overview
Table 107. Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 109. Boster Biological Technology Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Merck T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 114. Merck Recent Developments/Updates
Table 115. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 116. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 117. Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. ProSci Incorporated Corporation Information
Table 121. ProSci Incorporated Description and Business Overview
Table 122. ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 124. ProSci Incorporated Recent Developments/Updates
Table 125. Abbexa Corporation Information
Table 126. Abbexa Description and Business Overview
Table 127. Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 129. Abbexa Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. T Cell-specific Surface Glycoprotein CD28 Antibody Distributors List
Table 133. T Cell-specific Surface Glycoprotein CD28 Antibody Customers List
Table 134. T Cell-specific Surface Glycoprotein CD28 Antibody Market Trends
Table 135. T Cell-specific Surface Glycoprotein CD28 Antibody Market Drivers
Table 136. T Cell-specific Surface Glycoprotein CD28 Antibody Market Challenges
Table 137. T Cell-specific Surface Glycoprotein CD28 Antibody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of T Cell-specific Surface Glycoprotein CD28 Antibody
Figure 2. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size (2018-2029) & (US$ Million)
Figure 16. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (2018-2029) & (K Units)
Figure 17. Global T Cell-specific Surface Glycoprotein CD28 Antibody Average Price (US$/Unit) & (2018-2029)
Figure 18. T Cell-specific Surface Glycoprotein CD28 Antibody Report Years Considered
Figure 19. T Cell-specific Surface Glycoprotein CD28 Antibody Sales Share by Manufacturers in 2022
Figure 20. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest T Cell-specific Surface Glycoprotein CD28 Antibody Players: Market Share by Revenue in 2022
Figure 22. T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2018-2029)
Figure 25. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2018-2029)
Figure 26. United States T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2018-2029)
Figure 29. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2018-2029)
Figure 30. Germany T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2018-2029)
Figure 37. China T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2018-2029)
Figure 45. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2018-2029)
Figure 46. Mexico T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2018-2029)
Figure 51. Turkey T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Type (2018-2029)
Figure 55. Global Revenue Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Type (2018-2029)
Figure 56. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Application (2018-2029)
Figure 58. Global Revenue Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Application (2018-2029)
Figure 59. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2018-2029)
Figure 60. T Cell-specific Surface Glycoprotein CD28 Antibody Value Chain
Figure 61. T Cell-specific Surface Glycoprotein CD28 Antibody Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed